|
|
||||||||
Cardiology Department, Hospital Vall d'Hebron, 08035 Barcelona, Spain
Submitted 13 January 2003 ; accepted in final form 16 April 2003
| ABSTRACT |
|---|
|
|
|---|

m, JC-1) were assessed. ATP content was measured by
bioluminescence and mitochondrial swelling by spectrophotometry in isolated
mitochondria. Cariporide significantly attenuated the acidification of the
mitochondrial matrix induced by SI without modifying 
m
decay, and this effect was associated to a delayed ATP exhaustion and
increased mitochondrial Ca2+ load. These effects were
reproduced in sarcolemma-permeabilized cells exposed to SI. In these cells,
cariporide markedly attenuated the fall in mitochondrial pH induced by removal
of Na+ from the medium. In isolated mitochondria, cariporide
significantly reduced the rate and magnitude of passive matrix swelling
induced by Na+ acetate. In isolated rat hearts submitted to 40-min
ischemia at different temperatures (35.5°, 37°, or 38.5°C)
pretreatment with cariporide limited ATP depletion during the first 10 min of
ischemia and cell death (lactate dehydrogenase release) during reperfusion.
These effects were mimicked when a similar ATP preservation was achieved by
hypothermia and were abolished when the sparing effect of cariporide on ATP
was suppressed by hyperthermia. We conclude that cariporide acts at the
mitochondrial level, delaying mitochondrial matrix acidification and delaying
ATP exhaustion during ischemia. These effects can contribute to reduce cell
death secondary to ischemia-reperfusion.
ischemia; ions; infarction
More recently, it was proposed that NHE inhibitors could exert their
anti-ischemic effect at the mitochondrial level by favoring the opening of
mitochondrial ATP-sensitive K+ channels
(20). However, the mechanism
by which cariporide could open these channels, and the link between the
ATP-sensitive K+ channel opening and reduced cell death remain
elusive. NHE is not exclusive of plasmatic cell membranes, but it also exists
in the inner mitochondrial membrane
(22). H+ extrusion
from the mitochondrial matrix is coupled to electron transport during cell
respiration and results in a large H+ gradient between both sides
of the inner mitochondrial membrane. This chemical gradient, together with the
electrical charge difference across the inner mitochondrial membrane
(
m) generates the protonmotive force that moves
H+ into the mitochondrial matrix through the H+ channel
of the F0F1 complex (ATP synthase). H+ influx
into the mitochondrial matrix through the mitochondrial NHE (MNHE) constitutes
a form of H+ leakage not coupled to ATP synthesis that tends to
dissipate the energy stored as transmitochondrial membrane H+
gradient. During anoxia or ischemia, the normal mechanism of H+
extrusion associated to electron transport stops, mitochondrial matrix is
flooded with H+, H+ gradient collapses, and ATP
synthesis ceases (5) and may be
eventually replaced by ATP hydrolysis coupled to H+ extrusion
(4,
5). In the present study, we
investigated the hypothesis that inhibition of MNHE during ischemia slows both
acidification of the mitochondrial matrix and ATP hydrolysis and that the
resulting delay in energy depletion significantly contributes to the slowed
progression of ischemic injury and reduced cell death.
| METHODS |
|---|
|
|
|---|
Simulated ischemia in intact and permeabilized HL-1 cells. Experiments were performed on the stage of an inverted microscope (model IX70, Olympus) at x20 magnification fluorite objective (UplaFL, Olympus). For JC-1 fluorescence measurement a real-time laser confocal microscope was used (Nipkow system, QLC100, Visitech). Cells were submitted to 1 h of simulated ischemia at 37°C by incubation with a glucose-free buffer in the presence or in the absence of 7 µM cariporide. The buffer was composed of the following (in mM): 2 NaCN, 20 2-deoxyglucose (DOG), 140 NaCl, 3.6 KCl, 1.2 MgSO4, 2 CaCl2, 20 HEPES, or, when so stated, 24 NaHCO3, at pH 6.4. Experiments were performed in HEPES buffer for comparison with studies in membrane-permeabilized cells and replicated in bicarbonate-containing buffer to rule out the possible influence of the effects of cariporide on cytosolic pH in the absence of bicarbonate. These protocols were well tolerated, and, after reexposure to control containing glucose at pH 7.4 for 30 min (simulated reperfusion), the rate of cell death, assessed by propidium iodide, was <10% in all groups.
A subset of experiments was performed in myocytes permeabilized by 10-min incubation in an "intracellular-like" medium containing the following (in mM): 135 KCl, 10 NaCl, 0.5 KH2PO4, 0.5 MgCl2, and 20 HEPES (pH 7.2) as well as 10 µM digitonin. In these cells, ischemia was simulated by addition to the "intracellular-like" medium of NaCN (2 mM) and CaCl2 (10 µM) at pH 6.4.
Intramitochondrial [H+],
[Ca2+], and

m. Changes in mitochondrial [H+]
([H+]m), mitochondrial [Ca2+]
([Ca2+]m) and 
m were
monitored by a fluorescence-imaging system in cells subjected to simulated
ischemia either in the presence or in the absence of cariporide.
[H+]m was measured in cells loaded with 3 µM
2', 7'-bis(2-carboxyethyl)-5(6)carboxyfluorescein (BCECF;
Molecular Probes) (450/490 nm) for 1 h in medium 199, and the cells were then
washed and postincubated. To eliminate the cytosolic component in the overall
signal, the sarcolemma was permeabilized after the loading procedure.
Permeabilized cells were then submitted to 1 h of simulated ischemia, and
alternating excitation of the BCECF dye at wavelengths of 450 and 505 nm was
performed with the use of a fast-speed monochromator (Visitech). Emitted light
was collected with an air-cooled intensified digital camera, and 450-to-505-nm
ratios were calculated for each pixel at 10-s intervals from
background-substracted signal intensities in pairs of images consecutively
obtained at the two wavelengths. Color-coded 450-to-505-nm ratio images were
automatically generated and the average ratio was calculated for regions of
interest defined within the cells. Changes in these average ratio values
throughout time were analyzed. To measure
[Ca2+]m and 
m cells
underwent a loading protocol with 4 µM Rhod-2 and 10 µM JC-1 for 25 and
10 min, respectively, and were subjected to the same experimental protocol
described above except that excitation was performed at 552 nm for Rhod-2
probe and at 488 nm for JC-1 probe (emission fluorescence was recorded at 530
nm and at 590 nm). Results in fluorescence intensity were expressed as the
percentage of change respect to the initial value and for JC-1 probe as a
percentage of change respect to initial 590-to-530-nm emission ratio.
Na+-dependent changes in [H+]m. To confirm that 7 µM cariporide may inhibit NHE at the mitochondrial level, changes in [H+]m were monitored in permeabilized cells exposed to an abrupt removal of Na+ from the intracellular-like buffer in the presence and in the absence of the drug. Clonazepam (50 µM) was added throughout the Na+ removal protocol to block mitochondrial Na+/Ca2+, thus preventing Na+-dependent changes in [Ca2+]m.
Matrix swelling in isolated mitochondria. In a separate series of experiments, the potential effect of different concentrations of cariporide on mitochondrial matrix swelling was assessed spectrophotometrically in a suspension of isolated mitochondria. Rat heart mitochondria were isolated by differential centrifugation, according to the method described by Holmuhamedov et al. (12). Hearts were rapidly excised from pentobarbital-anesthetized rats (100 mg/kg) and placed in an ice-cold isolation buffer containing the following (in mM): 50 sucrose, 200 mannitol, 5 KH2PO4, 1 EGTA and 5 MOPS and 0.1% BSA (at pH 7.15) adjusted with KOH. After both atria were removed, ventricular myocardium was homogenized in three 20-s cycles using a Polytron (PT2100). Homogenized tissue was centrifuged 10 min at 750 g. The resulting supernatant containing the mitochondrial fraction was further centrifuged 20 min at 7,000 g, and the pellet was resuspended in the isolation buffer with no EGTA. Protein concentration of the mitochondrial suspension was determined by Bradford assay before the experiments.
Increases in mitochondrial matrix volume were determined as changes in the light scattering parameter of mitochondrial suspensions (8) with the use of a spectrophotometer (Lambda20, Perkin-Elmer). Light absorbance of the mitochondrial suspension (at 0.5 mg/ml protein) was measured at 546 nm. Passive swelling was induced with Na+ acetate solution at pH 7.2 (2). K+-acetate was added to mitochondria from a control group in which matrix swelling was absent. The effect of cariporide on MNHE at 2, 7, or 20 µM and the effect of 10-min preincubation with cariporide (7 µM) were measured as a reduction of mitochondrial swelling induced by Na+ acetate.
Cellular ATP content. ATP content was measured in cells frozen in liquid N2 by means of the Bioluminescent Somatic Cell Assay (Sigma Aldrich) after different periods of simulated ischemia.
Studies in isolated perfused rat heart. The relationship between the effect of cariporide on ATP depletion during ischemia and its protective effect against cell death induced by ischemia-reperfusion was studied in isolated, perfused hearts (n = 56). After intraperitoneal injection of pentobarbital sodium (100 mg/kg), the hearts were excised and perfused with a modified Krebs-Henseleit bicarbonate buffer composed of (in mM) 140 NaCl, 24 NaHCO3, 2.7 KCl, 0.4 KH2PO4, 1 MgSO4, 1.8 CaCl2, and 11 glucose and equilibrated with 95% O2-5% CO2 (pH 7.4) at 10 ml/min. The temperatures of the buffer and the heart chamber were digitally controlled. Left ventricular pressure was monitored with a water-filled latex balloon as previously described (7).
After 30 min of normoxic perfusion, the hearts were subjected to global nonflow ischemia at either 35.5°, 37°, or 38.5°C. Within each temperature group, hearts were allocated to receive 7 µM cariporide or vehicle during the last 10 min before ischemia. Four hearts from each of the resulting 6 groups were frozen in liquid N2 after 10 min of ischemia for determination of myocardial ATP content. The remaining hearts from each group (n = 45) were reperfused for 30 min after 40 min of ischemia. Lactate dehydrogenase (LDH) activity in the coronary effluent was spectrophotometrically measured as described (7). Myocardial ATP content was determined as described for cell cultures.
Statistical analysis. The homogeneity between groups was tested by ANOVA test; the effect of treatments on changes along time were studied by means of the MANOVA test; and the relationship between ATP content, time of onset of rigor contracture and LDH release was assessed by regression analysis (SPSS for Windows 8.0). To compare curves with complex and highly variable forms, as those for [Ca2+]m, a functional ANOVA test for functional data was used in which curve functions rather than isolated numerical observations are compared. A critical P value of 0.05 was used for all tests. All values are expressed as means ± SE.
| RESULTS |
|---|
|
|
|---|
|
Contribution of NHE to [Ca2+]m overload during simulated ischemia. [Ca2+]m started to rise very early after the initiation of simulated ischemia, a kinetics that clearly differs from that obtained in cytosolic compartment, in which Ca2+ starts to rise after a more prolonged time gap. Blockade of NHE during simulated ischemia with cariporide was associated to a more sustained [Ca2+]m overload. At the end of simulated ischemia, Rhod-2 fluorescence was 199 ± 29% of the preischemic value in control cells and 238 ± 30% in cariporide-treated cells (functional ANOVA test, P = 0.004; Fig. 2). In permeabilized cells, the initial rise in [Ca2+]m was followed by a plateau and a subsequent decay, probably reflecting Rhod-2 leakage in deenergized mitochondria and/or a net Ca2+ extrusion in the absence of further influx. In these cells, the relative increase in Rhod-2 fluorescence was attenuated respect to what was obtained in intact cells, probably because part of the fluorescent signal in intact cells comes from cytosolic compartment. As in intact cells, cariporide increased the overall amount of [Ca2+]m during simulated ischemia in permeabilized cells, and Rhod-2 fluorescence at the end of ischemia was 86 ± 10% of preischemic value in control cells and 127 ± 17% in cariporide-treated cells, P = 0.004 (Fig. 2). To assess whether the increase in [Ca2+]m was mediated by reverse operation of the mitochondrial Na+/Ca2+ exchanger, additional experiments were performed, in which this exchanger was inhibited by addition of clonazepam (50 µM) during simulated ischemia. This intervention did not result in a prevention of mitochondrial Ca2+ influx, but rather in an increase of the total mitochondrial Ca2+ load.
|
Mitochondrial depolarization during energy deprivation. The cells
exposed to simulated ischemia experienced a rapid fall in the

m, as measured by the decline in the 590/530 JC-1
emitted fluorescence. Mitochondrial depolarization reached its minimum level
at 1015 min, a time coincident with ATP exhaustion in this model. The
addition of cariporide during simulated ischemia did not preserve

m or significantly delayed its decline
(Fig. 3).
|
Effect of cariporide on intracellular ATP depletion during simulated ischemia. Intracellular ATP content started to decline immediately after the onset of simulated ischemia. In NaHCO3 buffer, the ATP fall reached 0.6 ± 0.1% of its initial level after 15 min, whereas in HEPES buffer, the ATP fall was significantly slower (data not shown). The presence of cariporide significantly delayed the rate of ATP exhaustion (Fig. 3).
Na+-dependent changes in [H+]m. Removal of Na+ from the intracellular-like buffer induced an abrupt increase in [H+]m in permeabilized cells. This increase was markedly attenuated by 7 µM cariporide (Fig. 4).
|
Effect of cariporide on mitochondrial swelling. The addition of Na+-acetate solution to a suspension of isolated rat heart mitochondria was immediately followed by passive matrix swelling, as determined spectrophotometrically by a decrease in the 546-nm absorbance. Cariporide (7 and 20 µM) significantly decreased the degree of mitochondrial matrix swelling induced by Na+-acetate and the rate at which it occurred, measured as the slope of the curve, whereas at 2 µM did not have any effect. Preincubation with 7 µM cariporide 10 min before the addition of Na+-acetate did not prevent matrix swelling development (Fig. 5).
|
Contribution of ATP preservation to protective effect of NHE inhibition
against ischemic-reperfusion cell death. In isolated rat hearts exposed
to nonflow ischemia at 37°C, pretreatment with cariporide significantly
delayed the onset of rigor contracture by
3 min, increased myocardial ATP
content observed after 10 min of ischemia by 41% (P < 0.01), and
reduced by >50% (P < 0.01) the extent of reperfusion-induced
hypercontracture, as assessed by peak left ventricular diastolic pressure, and
cell death, as assessed by LDH release. Reducing myocardial temperature during
ischemia had per se a strong effect on myocardial ATP content, and did mimic
the protection afforded by cariporide. Increasing myocardial temperature
accelerated ATP consumption during ischemia and attenuated the effects of the
drug. In the whole series of hearts, a close relationship was observed between
the rate of ATP depletion during the first 10 min of ischemia and the time of
onset of ischemic rigor (r = 0.85). Both variables were closely
correlated with LDH release during reperfusion (r = 0.99)
(Fig. 6). Nevertheless, these
relationships were not modified by cariporide. Multiple regression analysis
showed that time of rigor onset accurately predicted the extent of LDH release
during reperfusion, and that inclusion of treatment allocation in the
regression model did not significantly improve its predictive value.
|
| DISCUSSION |
|---|
|
|
|---|

m. This effect is associated to
slowed ATP depletion and is not a mere reflection of changes in cytosolic
cation concentration or pH, because it is observable in permeabilized cells.
The protective effect of cariporide against ATP depletion is also observable
in isolated rat hearts submitted to nonflow ischemia, and regression analysis
indicates that it fully accounts for the reduction in cardiomyocyte death
during subsequent reperfusion. These results are consistent with the
hypothesis that NHE inhibitors may protect myocardium against cell death
secondary to ischemia-reperfusion by acting on mitochondrial membrane, an
effect that results in less H+ entry into the matrix, and
preservation of transmembrane H+ gradient and ATP
concentration. Effect of cariporide on mitochondrial matrix acidification. Cariporide is an amiloride-related compound with a potent and highly selective inhibitory effect on NHE, in particular on the NHE1 isoform. The hypothesis that cariporide inhibits MNHE implies that it can cross cell membranes and reach mitochondria and that the mitochondrial exchanger can be inhibited by the drug. To our knowledge, no published study has measured the permeability of cell membranes to cariporide or other NHE inhibitors. However, calculation of the logarithmic number of partition coefficient for cariporide yields a value of 0.1 at a pH higher than its pKa (pH > 4.42). This predicts that cariporide can penetrate cell membranes and reach MNHE. The observation that cariporide markedly attenuates both the decrease in mitochondrial pH induced by removal of Na+ in permeabilized cells and passive matrix swelling induced by Na+ acetate in isolated mitochondria clearly indicates that the drug can inhibit MNHE in cardiomyocytes.
The importance of NHE at the inner mitochondrial membrane has been known for almost three decades. In higher eukaryotes, studies have found that MNHE is encoded by the NHE6 gene and has a molecular structure similar but not identical to sarcolemmal NHE (22), although recent reports question the unequivocal identification of NHE6 to the MNHE (21). MNHE can be effectively inhibited by sulfonylurea derivatives, including amiloride and more recently developed inhibitors of sarcolemmal NHE (2, 13, 14).
Under normal conditions, a gradient of H+ across the inner mitochondrial membrane, with the mitochondrial matrix more alkaline than the intermembrane or cytosolic spaces, is maintained by the active extrusion of H+ coupled with electron transport along the respiratory chain, as was first postulated by Mitchell in his chemiosmotic theory (19). During ischemia H+ extrusion stops, leading to matrix acidification and a progressive dissipation of H+ gradient. The results of the present study support the hypothesis that H+ influx into the mitochondrial matrix via MNHE significantly contributes to matrix acidification during ischemia. The attenuated matrix acidification observed in the presence of cariporide cannot be the indirect consequence of changes in cytosolic pH because it is observed for a constant pH in permeabilized cells. Moreover, previous studies have demonstrated a lack of effect of cariporide on cytosolic pH when other mechanisms of pH correction, like NaHCO3 cotransporter, are active. The effect of cariporide should be an enhancement of cytosolic acidosis that would not explain the reduced acidification of mitochondrial matrix. Because the H+ gradient across the inner mitochondrial membrane is one of the two components of the protonmotive force responsible for H+ flow through the F0 channel of the ATP synthase, and its reduction may determine ATP hydrolysis by the F1 unit of ATP coupled to H+ extrusion, delayed matrix acidification during simulated ischemia should be expected to result in attenuated rate of ATP depletion, as observed.
To our knowledge, no previous study has analyzed the effect of NHE inhibition on the increase in [Ca2+]m induced by ischemia. In a recent study (31), pretreatment with the selective NHE inhibitor SM-20550 was associated with attenuated Ca2+ overload in mitochondria obtained from rat hearts submitted to 40 min of ischemia and 20 min of reperfusion, a result in agreement with the protective effect of NHE inhibition against cell necrosis secondary to ischemia-reperfusion, but [Ca2+]m during ischemia was not measured. Our observation that cariporide, at concentrations that have been consistently found cardioprotective in isolated cells (25, 27) and intact myocardium in vivo (6, 16), enhanced mitochondrial Ca2+ accumulation during simulated ischemia may appear surprising. Although increased [Ca2+]m has been shown to have detrimental effects (4), there is a lack of information on the consequences of mitochondrial Ca2+ overload during ischemia. It has been previously shown that mitochondria with severe Ca2+ overload secondary to hypoxia or simulated ischemia may rapidly recover metabolic competence upon reoxygenation (9). Also, Ca2+ sequestration into mitochondria may attenuate cytosolic Ca2+ overload during ischemia and reperfusion. Moreover, extracellular acidification, a condition known to be strongly protective against hypoxic injury, is associated to enhanced increase of [Ca2+]m induced by hypoxia (see below).
Several recent reports have described the ability of mitochondria to accumulate Ca2+, acting as a local spatial buffering system often in close association with sarcoplasmic reticulum (24). The presence of 50 µM clonazepam during simulated ischemia did not result in a prevention of mitochondrial Ca2+ influx, but rather in an increase of the total mitochondrial Ca2+ load suggesting that reverse-mode operation of the mitochondrial Na+/Ca2+ exchanger is not responsible for mitochondrial Ca2+ influx during prolonged ischemia and may in fact represent a route of Ca2+ efflux.
Slowed ATP depletion during ischemic conditions. The present observations in cultured cardiomyocytes exposed to simulated ischemia and in intact myocardium submitted to zero-flow ischemia are in agreement with previous studies showing that NHE inhibition slows-down the rate of ATP depletion during ischemia and delays the onset of rigor contracture (6, 11, 25). Moreover, in the present study, modulation of the rate of ATP depletion during ischemia by modifying myocardial temperature within the physiological range (35.538.5°C) allowed us to evaluate the contribution of the effect of cariporide on ATP content to its protective effect against ischemia-reperfusion injury. Regression analysis demonstrated that the extent of cell death during reperfusion could be predicted by the degree of ATP depletion after 10 min of ischemia or by the time of onset of ischemic rigor contracture (an index of severe ATP depletion). This is consistent with studies showing that rigor contracture marks the onset of progressive cytosolic Ca2+ rise and the development of cell fragility (17) and with data showing that the time elapsed between development of rigor and reoxygenation or reperfusion, rather than total duration of hypoxia or ischemia, determines the outcome of reenergization (29). Cariporide shifted rigor onset and LDH release along the regression line without modifying it, and inclusion of the drug treatment in the model did not improve its predictive value. The protective effect of cariporide against cell death secondary to ischemia-reperfusion was, therefore, fully explained in this model by its effect on ATP decay during the ischemic period. This result is consistent with previous studies showing that cariporide needs to be present during the ischemic period to be protective (6, 16).
Study limitations. Because the present study was focused on the potential role of mitochondria in the protective effect of cariporide during ischemia, a cell system most adequate to this purpose was used.
HL1 cardiomyocyte cells accurately reproduce the changes in cytosolic composition induced by simulated ischemia in freshly isolated cardiomyocytes, but do not develop the changes in cell shape associated to ischemic rigor contracture and reenergization-induced hypercontracture. These changes in cell shape create important artifacts in nonratiometric fluorescent signals, including those from several important mitochondrial probes. On the other hand, these cells present the disadvantage of being more tolerant than freshly isolated cardiomyocytes to energy deprivation. This precluded any attempt to establish a direct correlation between the mitochondrial effects of cariporide during simulated ischemia and its protective effect against cell death, which occurs during reenergization. However, the direct correlation observed in intact rat hearts between the magnitude of the effect on ATP and the reduction of cell death suggests that the mitochondrial effects observed in cell cultures participate in the protection.
In conclusion, this study demonstrates that NHE inhibitors may have effects at the mitochondrial level, delaying mitochondrial matrix acidification and slowing down ATP depletion during ischemia. These results provide a new mechanism for the beneficial effect of NHE inhibitors against cell death secondary to ischemia-reperfusion and stresses the importance of mitochondria as targets for novel therapeutic approaches.
| DISCLOSURES |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. Javadov, A. Choi, V. Rajapurohitam, A. Zeidan, A. G. Basnakian, and M. Karmazyn NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition Cardiovasc Res, January 15, 2008; 77(2): 416 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Duan, R. A. Gross, and S.-S. Sheu Ca2+-dependent generation of mitochondrial reactive oxygen species serves as a signal for poly(ADP-ribose) polymerase-1 activation during glutamate excitotoxicity J. Physiol., December 15, 2007; 585(3): 741 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani and I. L. Ennis Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy Circulation, March 6, 2007; 115(9): 1090 - 1100. [Full Text] [PDF] |
||||
![]() |
S. Javadov, D. M. Purdham, A. Zeidan, and M. Karmazyn NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1722 - H1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz-Meana, D. Garcia-Dorado, E. Miro-Casas, A. Abellan, and J. Soler-Soler Mitochondrial Ca2+ uptake during simulated ischemia does not affect permeability transition pore opening upon simulated reperfusion Cardiovasc Res, September 1, 2006; 71(4): 715 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Pedersen, M. E. O'Donnell, S. E. Anderson, and P. M. Cala Physiology and pathophysiology of Na+/H+ exchange and Na+-K+-2Cl- cotransport in the heart, brain, and blood Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R1 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, H. Chen, D. B. Kintner, G. E. Shull, and D. Sun Decreased Neuronal Death in Na+/H+ Exchanger Isoform 1-Null Mice after In Vitro and In Vivo Ischemia J. Neurosci., December 7, 2005; 25(49): 11256 - 11268. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. I. Gursahani and S. Schaefer Acidification reduces mitochondrial calcium uptake in rat cardiac mitochondria Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2659 - H2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ruiz-Meana, P. Pina, D. Garcia-Dorado, A. Rodriguez-Sinovas, I. Barba, E. Miro-Casas, M. Mirabet, and J. Soler-Soler Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition J. Physiol., August 1, 2004; 558(3): 873 - 882. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |